HULC and/or MALAT1 overexpression resulted in early xenograft tumor formation compared to the control group (7.2days, 7.5days, 5.8 days versus 10.8days, respectively t-test, P < 0.01) (Fig. 3c). The gene discussed is HULC; the disease is neoplasm.